Replies to post #49552 on $heff's $tation of $tocks & $olid DD

[trade2much]

Sheff thanx for the AIS analysis you posted; I own it but not BPAX.

BOL -
T2M

[ronpopeil]

Jefferies Starts BioSante Pharmaceuticals (BPAX) at Buy, Sees More than 100% Upside
7:27 am ET 11/15/2011 - Street Insider
Jefferies initiates coverage on Biosante Pharmaceuticals (NASDAQ: BPAX) with a Buy rating and $5 price target, suggesting more than 100% upside.

The firm comments, "The story is entirely driven by LibiGel, a Ph3 testosterone gel, which would be the 1st drug for female sexual dysfunction. There's little doubt on efficacy, but P3 data in early Dec. comes next. Approvability hinges on safety; so far there's no evidence of CV events or breast cancer, but the results of a 3,656-patient trial won't mature until 3Q12."

For an analyst ratings summary and ratings history on BioSante Pharmaceuticals click here. For more ratings news on BioSante Pharmaceuticals click here.

Shares of BioSante Pharmaceuticals closed at $2.41 yesterday, with a 52 week range of $1.40-$4.02